
Immune Microenvironment on the Molecular Mechanisms and Therapeutic Targets of MAFLD
Metabolic dysfunction-associated fatty liver disease (MAFLD), characterized by liver steatosis, is one of the most prevalent chronic liver diseases globally.1 The disease was redefined in 2023, with the name changing from non-alcoholic fatty liver disease …